366 related articles for article (PubMed ID: 16690763)
1. Prevalence and management of rheumatoid arthritis in the general population of Greece--the ESORDIG study.
Andrianakos A; Trontzas P; Christoyannis F; Kaskani E; Nikolia Z; Tavaniotou E; Georgountzos A; Krachtis P;
Rheumatology (Oxford); 2006 Dec; 45(12):1549-54. PubMed ID: 16690763
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of rheumatic diseases in Greece: a cross-sectional population based epidemiological study. The ESORDIG Study.
Andrianakos A; Trontzas P; Christoyannis F; Dantis P; Voudouris C; Georgountzos A; Kaziolas G; Vafiadou E; Pantelidou K; Karamitsos D; Kontelis L; Krachtis P; Nikolia Z; Kaskani E; Tavaniotou E; Antoniades C; Karanikolas G; Kontoyanni A;
J Rheumatol; 2003 Jul; 30(7):1589-601. PubMed ID: 12858464
[TBL] [Abstract][Full Text] [Related]
3. The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial.
Rantalaiho V; Korpela M; Hannonen P; Kautiainen H; Järvenpää S; Leirisalo-Repo M; Hakala M; Puolakka K; Julkunen H; Luosujärvi R; Möttönen T;
Arthritis Rheum; 2009 May; 60(5):1222-31. PubMed ID: 19404945
[TBL] [Abstract][Full Text] [Related]
4. Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis.
Maradit-Kremers H; Nicola PJ; Crowson CS; O'Fallon WM; Gabriel SE
J Rheumatol; 2006 Feb; 33(2):248-55. PubMed ID: 16358365
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic strategies in rheumatoid arthritis over a 40-year period.
Kremers HM; Nicola P; Crowson CS; O'Fallon WM; Gabriel SE
J Rheumatol; 2004 Dec; 31(12):2366-73. PubMed ID: 15570636
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of symptomatic knee, hand, and hip osteoarthritis in Greece. The ESORDIG study.
Andrianakos AA; Kontelis LK; Karamitsos DG; Aslanidis SI; Georgountzos AI; Kaziolas GO; Pantelidou KV; Vafiadou EV; Dantis PC;
J Rheumatol; 2006 Dec; 33(12):2507-13. PubMed ID: 17143985
[TBL] [Abstract][Full Text] [Related]
7. The burden of the rheumatic diseases in the general adult population of Greece: the ESORDIG study.
Andrianakos AA; Miyakis S; Trontzas P; Kaziolas G; Christoyannis F; Karamitsos D; Karanikolas G; Dantis P;
Rheumatology (Oxford); 2005 Jul; 44(7):932-8. PubMed ID: 15840597
[TBL] [Abstract][Full Text] [Related]
8. Lag time between onset of symptoms and access to rheumatology care and DMARD therapy in a cohort of patients with rheumatoid arthritis.
Hernández-García C; Vargas E; Abásolo L; Lajas C; Bellajdell B; Morado IC; Macarrón P; Pato E; Fernández-Gutiérrez B; Bañares A; Jover JA
J Rheumatol; 2000 Oct; 27(10):2323-8. PubMed ID: 11036824
[TBL] [Abstract][Full Text] [Related]
9. Advance and unmet need of health care for patients with rheumatoid arthritis in the German population--results from the German Rheumatoid Arthritis Population Survey (GRAPS).
Westhoff G; Schneider M; Raspe H; Zeidler H; Runge C; Volmer T; Zink A
Rheumatology (Oxford); 2009 Jun; 48(6):650-7. PubMed ID: 19321515
[TBL] [Abstract][Full Text] [Related]
10. [Descriptive study of the use of DMARD in patients with rheumatoid arthritis or persistent arthritis who start drug treatment in Spain (FIRST)].
Blanco FJ; Ballina J; Carbonell J; Martín-Mola E; Tornero J; Ramírez E; Galván J
Reumatol Clin; 2011; 7(2):88-93. PubMed ID: 21794790
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of rheumatoid arthritis in Tucumán, Argentina.
Spindler A; Bellomio V; Berman A; Lucero E; Baigorria M; Paz S; Garrone N; Torres AI; Romano O; Carraccio A; Leal O; Bazzano A; Vazquez D; Pera O; Arquez G; Valdez M; Lazaro H; Rengel S; Acosta E; Santana M
J Rheumatol; 2002 Jun; 29(6):1166-70. PubMed ID: 12064829
[TBL] [Abstract][Full Text] [Related]
12. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Hyrich KL; Watson KD; Silman AJ; Symmons DP;
Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of adult rheumatoid arthritis in northwest Greece 1987-1995.
Drosos AA; Alamanos I; Voulgari PV; Psychos DN; Katsaraki A; Papadopoulos I; Dimou G; Siozos C
J Rheumatol; 1997 Nov; 24(11):2129-33. PubMed ID: 9375871
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and management of rheumatoid arthritis.
Rindfleisch JA; Muller D
Am Fam Physician; 2005 Sep; 72(6):1037-47. PubMed ID: 16190501
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of rheumatoid arthritis and hepatitis C in those age 60 and older in a US population based study.
Hsu FC; Starkebaum G; Boyko EJ; Dominitz JA
J Rheumatol; 2003 Mar; 30(3):455-8. PubMed ID: 12610800
[TBL] [Abstract][Full Text] [Related]
16. Treatment of older adult patients diagnosed with rheumatoid arthritis: improved but not optimal.
Schmajuk G; Schneeweiss S; Katz JN; Weinblatt ME; Setoguchi S; Avorn J; Levin R; Solomon DH
Arthritis Rheum; 2007 Aug; 57(6):928-34. PubMed ID: 17665462
[TBL] [Abstract][Full Text] [Related]
17. Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis.
Lacaille D; Guh DP; Abrahamowicz M; Anis AH; Esdaile JM
Arthritis Rheum; 2008 Aug; 59(8):1074-81. PubMed ID: 18668604
[TBL] [Abstract][Full Text] [Related]
18. Prevalence survey of rheumatoid arthritis and spondyloarthropathy in Lithuania.
Adomaviciute D; Pileckyte M; Baranauskaite A; Morvan J; Dadoniene J; Guillemin F
Scand J Rheumatol; 2008; 37(2):113-9. PubMed ID: 18415768
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of rheumatoid arthritis in the South-Transdanubian region of Hungary based on a representative survey of 10,000 inhabitants.
Kiss CG; Lövei C; Sütö G; Varjú C; Nagy Z; Füzesi Z; Illés T; Czirják L
J Rheumatol; 2005 Sep; 32(9):1688-90. PubMed ID: 16142861
[TBL] [Abstract][Full Text] [Related]
20. Trends in disease modifying antirheumatic drug prescription in early rheumatoid arthritis are influenced more by hospital setting than patient or disease characteristics.
Carli C; Ehlin AG; Klareskog L; Lindblad S; Montgomery SM
Ann Rheum Dis; 2006 Aug; 65(8):1102-5. PubMed ID: 16322085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
